Clinical Trial Update: Dead Mesenchymal Stem Cells for Radiation Lung Injury [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on dead mesenchymal stem cells for radiation-induced lung injury across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation-induced Lung Injury

Drugs mentioned

• dead mesenchymal stem cells

Snippet

Sponsor: Sichuan University | Conditions: Radiation Lung Injury | Phase 1, Phase 2 | Status: UNKNOWN